Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03401931

Artificial Intelligence Use for the Detection of Atrial Fibrillation Drivers

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Hospital St. Joseph, Marseille, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

pilot clinical study, multicenter, prospective, open, nonrandomized

Detailed description

The hypothesis is that ablation targeting PVI alone for the treatment of persistent AF is less efficient that ablation targeting electrophysiologic areas with spatio-temporal-dispersion with or without PVI

Conditions

Timeline

Start date
2018-01-09
Primary completion
2018-01-09
Completion
2018-01-09
First posted
2018-01-17
Last updated
2020-04-28

Locations

3 sites across 2 countries: France, Netherlands

Source: ClinicalTrials.gov record NCT03401931. Inclusion in this directory is not an endorsement.